Tools
Search
Import
Library
Explore
Videos
Channels
Figures
Atmrix
About
Tools
Search
Import
Library
Explore
Videos
Channels
Figures
Atmrix
About
Go Back
CP
Chris Palmer
03/31/25
@ Andrew Huberman
Research is underway to establish biomarkers that can predict mitochondrial dysfunction and potentially identify children at risk for neurodevelopmental disorders.
Video
AH
Transform Your Mental Health With Diet & Lifestyle | Dr. Chris Palmer
@ Andrew Huberman
03/31/25
Related Takeaways
CP
Chris Palmer
03/31/25
@ Andrew Huberman
There is currently no single blood test for mitochondrial health, but various biomarkers can indicate metabolic dysregulation.
CP
Chris Palmer
03/31/25
@ Andrew Huberman
We need to develop evidence-based tools for prospective parents to assess their metabolic health and that of their children to improve health outcomes.
CP
Chris Palmer
03/31/25
@ Andrew Huberman
Metabolic health influences neurodevelopment, and as metabolic health declines, we can expect an increase in neurodevelopmental disorders.
CP
Chris Palmer
03/31/25
@ Andrew Huberman
Vitamin B12, folate, and iron are essential for mitochondrial function, and deficiencies in these vitamins can lead to various neuropsychiatric disorders.
CP
Chris Palmer
03/31/25
@ Andrew Huberman
Inflammation can impair mitochondrial function, which is crucial for brain health, and high levels of inflammation are linked to various neuropsychiatric symptoms.
CP
Chris Palmer
03/31/25
@ Andrew Huberman
Metabolic health, particularly mitochondrial health, can be leveraged to treat and potentially cure psychiatric disorders like schizophrenia, autism, depression, bipolar disorder, and ADHD.
AH
Andrew Huberman
07/20/20
@ Rich Roll
The addiction treatment community needs biomarkers to identify individuals at risk of relapse early on.
CP
Chris Palmer
03/31/25
@ Andrew Huberman
A ketogenic diet should be considered as a potential treatment option for children with neurodevelopmental conditions, similar to its use in epilepsy.
CP
Chris Palmer
03/31/25
@ Andrew Huberman
Only 7% of Americans are healthy across all five biomarkers of metabolic syndrome, highlighting a public health crisis that impacts neurodevelopment.